Repurposing of drugs is quickly becoming a fast growing market, expected to reach over $30 billion worldwide by 2020. In this webinar, Michael Best's Lisa L. Mueller and Johns Hopkins Technology Ventures' (JHTV) Carol J. Burns, Ph.D., will discuss what drug repurposing is, reasons for repurposing, the main players in the industry, and the scientific, intellectual property, and regulatory opportunities and challenges associated with such products in the U.S., Europe, and Japan. Additionally, some legislative proposals directed towards repurposing will be examined.
We will apply for CLE credit in WI, CO, IL, MT, NC, TX, UT, and VA (if applicable).
To view past recordings, please visit our Life Sciences Webinar Series Library.